DNCA Finance’s Thermo Fisher Scientific TMO Stock Holding History

DNCA Finance’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.05M	Buy	14,335 +9,065	+172%	+$4.92M	0.4%	43
2025 Q4	$3.05M	Sell	5,270 -530	-9%	-$300K	0.18%	64
2025 Q3	$2.81M	Sell	5,800 -15,150	-72%	-$7.05M	0.19%	63
2025 Q2	$8.49M	Sell	20,950 -2,000	-9%	-$836K	0.65%	42
2025 Q1	$11.4M	Sell	22,950 -3,650	-14%	-$1.98M	0.95%	29
2024 Q4	$13.8M	Buy	26,600 +3,300	+14%	+$1.81M	1.08%	29
2024 Q3	$14.4M	Sell	23,300 -3,400	-13%	-$2.01M	1.24%	25
2024 Q2	$14.8M	Buy	+26,700	New	+$15.3M	1.27%	20

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DNCA Finance's TMO Position: Q1 2026 in Review

DNCA Finance increased its Thermo Fisher Scientific (TMO) stake by 172% in Q1 2026, buying an estimated $4.92M and bringing the position to 14,335 shares worth $7.05M. The position accounts for 0.4% of the portfolio, ranked #43.

DNCA Finance first reported a position in TMO in Q2 2024 and has held it in 8 quarters since. The position peaked at $14.8M in Q2 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

DNCA Finance held 14,335 shares of Thermo Fisher Scientific worth $7.05M as of Q1 2026.
DNCA Finance bought 9,065 Thermo Fisher Scientific shares in Q1 2026, an estimated $4.92M.
Thermo Fisher Scientific made up 0.4% of DNCA Finance's portfolio in Q1 2026, its #43 holding.
DNCA Finance first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 8 quarters since.
DNCA Finance's Thermo Fisher Scientific position peaked at $14.8M in Q2 2024.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on DNCA Finance's 13F filing for Q1 2026, filed 14 May 2026.